Related references
Note: Only part of the references are listed.
Article
Medicine, General & Internal
Renin Chang et al.
Summary: This retrospective cohort study reveals that there is a significant association between COVID-19 and the risk of autoimmune diseases. However, further research is needed to replicate these findings in an independent dataset and understand the underlying mechanisms.
Article
Rheumatology
Falko Tesch et al.
Summary: In this large cohort study, we found that patients with prior COVID-19 infection have a higher risk of developing autoimmune diseases compared to those without COVID-19.
CLINICAL RHEUMATOLOGY
(2023)
Article
Dermatology
Hyun Jeong Ju et al.
Summary: This nationwide population-based study conducted in South Korea investigated the incidence and risk of autoimmune connective tissue disorders following mRNA-based COVID-19 vaccination. The results suggest that the risk of most autoimmune connective tissue disorders is not significantly increased in vaccinated individuals compared to controls. However, caution is necessary when interpreting the results for rare outcomes.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
(2023)
Letter
Cardiac & Cardiovascular Systems
Joy Jiang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2023)
Letter
Gastroenterology & Hepatology
Antonio Tursi et al.
Summary: A 47-year-old woman developed a new occurrence of Crohn's disease after the coronavirus pandemic, which is an uncommon phenomenon. This suggests that severe acute respiratory syndrome coronavirus 2 may trigger inflammatory bowel disease in individuals who are predisposed.
INFLAMMATORY BOWEL DISEASES
(2022)
Article
Biochemistry & Molecular Biology
Yan Xie et al.
Summary: Individuals with COVID-19, even those who were not hospitalized during the acute phase of the infection, are at an increased long-term risk of various cardiovascular disorders. A study using national healthcare databases found that beyond the first 30 days after infection, individuals with COVID-19 have an elevated risk of developing cerebrovascular disorders, heart diseases, and other cardiovascular complications. The risk increases depending on the care setting during the acute phase.
Review
Immunology
Elahe Aleebrahim-Dehkordi et al.
Summary: Cytokines produced by T helper cells play crucial roles in host defense against viruses, with Th1 cells essential for defense against intracellular pathogens and Th2 cells critical for parasite elimination. Diseases caused by SARS-CoV-2 and H1N1 influenza have led to global epidemics, with pulmonary immunopathology being a leading cause of mortality. Inadequate or excessive levels of specific cytokines can have adverse effects on the body during these viral infections.
TRANSPLANT IMMUNOLOGY
(2022)
Article
Immunology
Azam Safary et al.
Summary: Vaccination against COVID-19 is important for achieving herd immunity and controlling the pandemic. However, a small number of people may develop autoimmune rheumatic diseases (ARDs) as a rare adverse reaction to the vaccines. This study identifies individuals who developed de-novo ARDs after COVID-19 vaccination, with a higher prevalence among those who received the AstraZeneca vaccine. Prompt diagnosis and treatment can prevent irreversible organ damage.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2022)
Review
Immunology
Yhojan Rodriguez et al.
Summary: This study suggests a potential association between COVID-19 vaccination and autoimmune and inflammatory diseases. New-onset conditions were more common, with immune thrombocytopenia, myocarditis, and Guillain-Barre syndrome being the most common diseases associated with new-onset events. Some diseases may relapse after vaccination. Further large-scale studies are needed to validate this relationship.
JOURNAL OF AUTOIMMUNITY
(2022)
Article
Biochemistry & Molecular Biology
Evan Xu et al.
Summary: Individuals with COVID-19 have an increased risk of developing a range of neurologic disorders at 12 months, even if they were not hospitalized during the acute phase of the infection.
Article
Medicine, General & Internal
Saurabh Kataria et al.
Summary: This case report presents a patient with rheumatoid arthritis who developed ANCA-associated vasculitis after a COVID-19 infection. The patient presented with dyspnea and hemoptysis, consistent with pulmonary-renal syndrome. Clinical, radiological, and serological findings were consistent with pauci-immune crescentic glomerulonephritis, and the patient showed improvement after treatment with rituximab and methylprednisolone.
CUREUS JOURNAL OF MEDICAL SCIENCE
(2022)
Review
Endocrinology & Metabolism
Dirk Mueller-Wieland et al.
Summary: The global pandemic caused by the emergence of SARS-CoV-2 has led to a high number of deaths due to COVID-19. Older age and the presence of chronic diseases are associated with a higher severity and mortality risk of COVID-19. This review focuses on the impact of chronic diseases associated with the cardiovascular system, such as obesity, diabetes mellitus, hypertension, and cardiovascular disease, on SARS-CoV-2 infection and COVID-19. It also discusses the recommendations and guidance from international scientific associations.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
(2022)
Article
Biochemistry & Molecular Biology
Sara Ibrahim Taha et al.
Summary: In this study, the prevalence of post-COVID arthritis was 37%, with associations found between arthritis and old age, smoking, and arthralgia. The results indicated a strong association with inflammatory markers (ESR and CRP) and an insignificant association with serologic markers of autoimmunity (ANA and anti-CCP) in post-COVID arthritis. It was concluded that the underlying mechanism of post-COVID arthritis is primarily due to the hyperinflammatory process associated with COVID-19 infection, and IL-6 levels before therapy can predict post-COVID arthritis allowing for early management.
EUROPEAN CYTOKINE NETWORK
(2021)
Letter
Rheumatology
Veerle F. A. M. Derksen et al.
ANNALS OF THE RHEUMATIC DISEASES
(2021)
Review
Infectious Diseases
Boyan K. Tsankov et al.
Summary: Children with comorbidities are at higher risk of severe COVID-19 infection and associated mortality, with a significantly increased risk compared to healthy children. Obese children also have a higher risk of COVID-19 infection.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
(2021)
Article
Medicine, General & Internal
Anthony C. Gordon et al.
Summary: Interleukin-6 receptor antagonists tocilizumab and sarilumab were found to improve outcomes, including survival, in critically ill patients with Covid-19 receiving organ support in ICUs according to an ongoing international trial. The efficacy of these treatments has been confirmed, with patients benefiting from the therapy.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Immunology
Amirhossein Mardi et al.
Summary: COVID-19 infection may lead to cytokine storms, causing severe inflammation and organ damage. Interleukin-1 plays a crucial role in this process, and the use of IL-1 inhibitors may be beneficial in controlling the inflammatory response.
Review
Cell Biology
Abraham Edgar Gracia-Ramos et al.
Summary: There is mounting evidence that COVID-19 can trigger the development of new-onset systemic and rheumatic autoimmune diseases, mainly involving vasculitis and arthritis. Further research is needed to understand the link between SARS-CoV-2 and these autoimmune diseases for early diagnosis and appropriate management.
Review
Gastroenterology & Hepatology
Aqsa Ahmad et al.
Summary: The outbreak of COVID-19 has posed challenges to healthcare systems, particularly in terms of clinical management and infection transmission related to hepatic-disease comorbidities. COVID-19 patients with altered liver function due to hepatitis infection and cholestasis experience worse health outcomes. There are various ways in which SARS-CoV-2 can induce liver injury, including direct cytopathic effects, immune-mediated damage, hypoxia, and sepsis.
WORLD JOURNAL OF GASTROENTEROLOGY
(2021)
Review
Immunology
Hannah Zacharias et al.
Summary: COVID-19 infection can lead to various rheumatological complications such as inflammatory arthritis, SLE and renal disease, vasculitis, rhabdomyolysis, and myositis. Evidence of large vessel vasculitis has also been reported in 'long COVID' patients.
AUTOIMMUNITY REVIEWS
(2021)
Article
Medicine, Research & Experimental
Shuang Hua et al.
Summary: Metabolic complications such as type 2 diabetes, obesity, and hypertension play a crucial role in the morbidity and mortality of COVID-19 patients. Treatment decisions for COVID-19 patients with such comorbidities should be made cautiously based on emerging evidence.
BIOMEDICINE & PHARMACOTHERAPY
(2021)
Article
Medicine, General & Internal
Manu Shankar-Hari et al.
Summary: This study identified 27 clinical trials and found that the use of IL-6 antagonists was associated with lower 28-day all-cause mortality in patients hospitalized for COVID-19 compared to usual care or placebo. Different risk effects were observed between tocilizumab and sarilumab, increasing understanding of the treatment with these drugs.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2021)
Article
Biochemistry & Molecular Biology
Mugdha Mohkhedkar et al.
Summary: The study identifies 28 human proteins with regions homologous to SARS-CoV-2 peptides as potential autoantigens, explaining the occurrence of autoimmune conditions following COVID-19 infection. These autoantigens are found to be distributed widely in tissues, suggesting their involvement in multi-organ manifestations through molecular mimicry. The report may guide future antigen-specific studies for management of extrapulmonary symptoms of COVID-19.
MOLECULAR IMMUNOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Evdoxia Kyriazopoulou et al.
Summary: The SAVE-MORE phase 3 study demonstrated the efficacy of anakinra, an IL-1 alpha/beta inhibitor, in patients with COVID-19 and high serum levels of soluble plasminogen activator receptor, showing significant reduction in clinical deterioration and decreased 28-day mortality.
Review
Rheumatology
Tugba Izci Duran et al.
Summary: Two rare cases of antineutrophil cytoplasmic antibody-associated vasculitis (AAV) were reported in patients recently diagnosed with COVID-19, leading to acute kidney injury and pulmonary lesions. Treatment with methylprednisolone, cyclophosphamide, and plasma exchange improved renal function in these cases. Additionally, a systematic review revealed four cases of new-onset AAV following COVID-19 infection.
RHEUMATOLOGY INTERNATIONAL
(2021)
Review
Cell Biology
Diana Martonik et al.
Summary: COVID-19, caused by SARS-CoV-2 virus, is an acute infectious disease of the respiratory system transmitted through droplets and contaminated objects. The immune system response is crucial in defending against viral infection but an overreaction may harm the body. Th17 cells play a significant role in the pathogenesis of COVID-19.
Article
Immunology
Chen Xu et al.
Summary: The study found that 20.16% of COVID-19 patients tested positive for rheumatoid-associated autoantibodies, with IgM-RF predominantly present in critically ill patients and IgA-RF mainly present in mild patients. The antibodies peaked in the later phase of the disease and lasted for a longer time.
JOURNAL OF INFLAMMATION RESEARCH
(2021)
Article
Medicine, General & Internal
Maryam Mobini et al.
Summary: This study investigated the presence of vasculitis-associated autoantibodies and complement levels in 40 patients with severe or critical COVID-19, finding abnormalities in some patients. Specifically, decreases in complement levels may indicate a critical state of the disease and could be used to make decisions regarding treatment initiation.
JOURNAL OF RESEARCH IN MEDICAL SCIENCES
(2021)
Article
Gastroenterology & Hepatology
Kuppusamy Senthamizhselvan et al.
Summary: Immune dysregulation associated with COVID-19 may lead to the development of autoimmune diseases, such as ileocolonic Crohn's disease in this case. Treatment with oral corticosteroids and sulfasalazine was effective in achieving remission of symptoms.
ACG CASE REPORTS JOURNAL
(2021)
Review
Medicine, Research & Experimental
Jae Seok Kim et al.
Summary: Severe COVID-19 is characterized by systemic hyper-inflammation and cytokine storm, often leading to acute respiratory distress syndrome and multiple organ failure. Treatment of COVID-19 cytokine storm is crucial, with anti-inflammatory therapies playing a significant role. Various approaches are being used, including new cytokine-targeted therapies, to address the cytokine storm associated with COVID-19.
Letter
Rheumatology
Carmine Gazzaruso et al.
CLINICAL RHEUMATOLOGY
(2020)
Editorial Material
Cardiac & Cardiovascular Systems
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION
(2020)
Letter
Critical Care Medicine
Lei Fang et al.
LANCET RESPIRATORY MEDICINE
(2020)
Letter
Rheumatology
Panayiotis G. Vlachoyiannopoulos et al.
ANNALS OF THE RHEUMATIC DISEASES
(2020)
Editorial Material
Rheumatology
Caroline Galeotti et al.
NATURE REVIEWS RHEUMATOLOGY
(2020)
Review
Rheumatology
Sahar Najafi et al.
CLINICAL RHEUMATOLOGY
(2020)
Article
Biochemistry & Molecular Biology
Diane Marie Del Valle et al.
Article
Multidisciplinary Sciences
Paul Bastard et al.
Article
Multidisciplinary Sciences
Sang Chul Lee et al.
SCIENTIFIC REPORTS
(2020)
Article
Virology
Ana Carolina Gadotti et al.
Review
Rheumatology
Dennis McGonagle et al.
LANCET RHEUMATOLOGY
(2020)
Article
Dermatology
Solam Lee et al.
Review
Immunology
Alessandro Poggi et al.
FRONTIERS IN IMMUNOLOGY
(2019)
Review
Respiratory System
David Bennett et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE
(2019)
Article
Public, Environmental & Occupational Health
Juneyoung Lee et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
(2017)
Editorial Material
Public, Environmental & Occupational Health
Sang Cheol Seong et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
(2017)
Article
Dermatology
Pigment Cell & Melanoma Research
(2016)
Article
Medicine, General & Internal
Dominique Valeyre et al.
Review
Microbiology
RS Fujinami et al.
CLINICAL MICROBIOLOGY REVIEWS
(2006)
Article
Genetics & Heredity
M Mori et al.
JOURNAL OF HUMAN GENETICS
(2005)
